抗反流黏膜切除术与下食管括约肌射频消融治疗GERD的疗效与安全性:系统评价与Meta分析
该系统评价与Meta分析纳入66项研究共3767例患者,比较抗反流黏膜切除术(ARMS)与Stretta射频消融治疗GERD的疗效与安全性。两者在患者满意度、PPI使用、GERD-HRQL及DeMeester评分改善方面相似,但ARMS的总并发症发生率及狭窄、出血、穿孔风险均高于Stretta。
要点
- ARMS与Stretta均能显著减少PPI使用并改善GERD-HRQL和DeMeester评分,两者疗效相似。
- ARMS患者满意度加权汇总率为65%,Stretta为77%。
- ARMS总并发症发生率为25%,高于Stretta的17%,且狭窄、出血、穿孔风险更高。
核心结论
- Stretta和ARMS均为治疗GERD的有效内镜治疗方式,临床疗效相似,但ARMS术后吞咽困难、出血和穿孔风险增加不应被低估。
研究设计与样本
- 系统评价与Meta分析,检索MEDLINE数据库,纳入分析ARMS和Stretta结局的原始文章,共66项研究、3767例患者,其中3074例(81.60%)接受Stretta,693例(18.40%)接受ARMS。
主要发现
- 患者满意度加权汇总率:ARMS为65%(95%CI 52-76),Stretta为77%(95%CI 64-87)。
- PPI使用率:ARMS从100%降至40.18%,Stretta从99.42%降至48.51%,组间比较P=0.20。
- GERD-HRQL评分:ARMS从术前19.75降至术后8.24,Stretta从术前21.02降至术后10.45,组间比较P=0.70。
- DeMeester评分:ARMS从术前44.99降至术后15.02,Stretta从术前52.29降至术后28.99,组间比较P=0.48。
- ARMS总并发症发生率为25%,高于Stretta的17%(P=0.001);与Stretta相比,ARMS的狭窄风险OR为13.03(95%CI 7.83-21.71),出血风险OR为13.16(95%CI 8.60-20.15),穿孔风险OR为13.03(95%CI 7.82-21.71)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: GERD affects 10% to 30% of the population. Endoscopic antireflux therapies have been proposed for carefully selected patients. In this study, we compared outcomes between endoscopic antireflux mucosectomy (ARMS) and endoscopic radiofrequency ablation of the lower esophageal sphincter (Stretta procedure) for the treatment of GERD. METHODS: A systematic review using the MEDLINE database was performed to identify original articles analyzing outcomes after ARMS and Stretta procedures. The main outcomes were patient satisfaction, GERD Health-Related Quality of Life (GERD-HRQL) scores, proton pump inhibitor (PPI) use, and DeMeester scores. Secondary outcomes were postprocedural adverse events. A meta-analysis of proportions and linear regression models was used to assess the effect of each endoscopic procedure on the different outcomes. RESULTS: Sixty-six studies comprising 3767 patients were included, with 3074 patients (81.60%) undergoing Stretta and 693 (18.40%) ARMS. The weighted pooled patient satisfaction rates were 65% (95% confidence interval [CI], 52-76) for ARMS and 77% (95% CI, 64-87) for Stretta. Both treatments significantly reduced PPI use (from 100% to 40.18% for ARMS vs from 99.42% to 48.51% for Stretta, P = .20) and improved GERD-HRQL scores (pre 19.75 to post 8.24 for ARMS vs pre 21.02 to post 10.45 for Stretta, P = .70). DeMeester scores improved similarly after both procedures (pre 44.99 to post 15.02 for ARMS vs pre 52.29 to post 28.99 for Stretta, P = .48). ARMS was associated with higher overall morbidity (25% vs 17%, P = .001) and greater risks of stricture (odds ratio [OR], 13.03; 95% CI, 7.83-21.71), bleeding (OR, 13.16; 95% CI, 8.60-20.15), and perforation (OR, 13.03; 95% CI, 7.82-21.71) compared with Stretta. CONCLUSIONS: Both Stretta and ARMS are effective endoscopic treatment modalities for GERD. Although their clinical efficacy appears to be similar, the increased risk of dysphagia, bleeding, and perforation after ARMS should not be underestimated.
引用
- Angeramo CA, Lendoire M, Herbella FAM, et al. Efficacy and safety of antireflux mucosectomy versus radiofrequency ablation of the lower esophageal sphincter for the treatment of GERD: a systematic review and meta-analysis. Gastrointest Endosc. 2024. PMID: 39716536. doi:10.1016/j.gie.2024.12.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。